Increased SOX10, p16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-activated Low-grade Gliomas From Piloid Gliosis.

MLA

Tang, Vivian, et al. “Increased SOX10, P16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-Activated Low-Grade Gliomas From Piloid Gliosis.” The American Journal of Surgical Pathology, Jan. 2025. EBSCOhost, https://doi.org/10.1097/PAS.0000000000002353.

APA

Tang, V., Zhang, K. Y., Mirchia, K., Lu, R., Guney, E., Terry, M., Ligon, A. H., Ligon, K. L., Eberhart, C. G., Perry, A., & Lucas, C.-H. G. (2025). Increased SOX10, p16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-activated Low-grade Gliomas From Piloid Gliosis. The American Journal of Surgical Pathology. https://doi.org/10.1097/PAS.0000000000002353

Chicago

Tang, Vivian, Kevin Y Zhang, Kanish Mirchia, Rufei Lu, Ekin Guney, Merryl Terry, Azra H Ligon, et al. 2025. “Increased SOX10, P16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-Activated Low-Grade Gliomas From Piloid Gliosis.” The American Journal of Surgical Pathology, January. doi:10.1097/PAS.0000000000002353.